Skip to content

Fulgent Genetics, Inc.

FLGT

CIK 0001674930

← back to feed
Revenue (TTM)
$310.47M
+13.8% YoY Q1 Apr 2026
Net Income (TTM)
−$61.92M
−41.7% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$0.11
−266.7% YoY Q1 Apr 2026
Gross Margin
38.6%
Q1 Apr 2026
Operating Margin
-28.8%
Q1 Apr 2026
Net Margin
-19.9%
Q1 Apr 2026
Free Cash Flow (TTM)
−$13.99M
Q1 Apr 2026
Cash
$23.4M
Q1 Apr 2026
Total Debt
—
Q1 Apr 2026
Shares Outstanding
28.4M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings